Stocks and Investing Stocks and Investing
Fri, September 27, 2024
Thu, September 26, 2024

Luca Issi Reiterated (ARWR) at Buy and Held Target at $42 on, Sep 26th, 2024


Published on 2024-10-28 14:29:04 - WOPRAI, Luca Issi
  Print publication without navigation


Luca Issi of RBC Capital, Reiterated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy and Held Target at $42 on, Sep 26th, 2024.

Luca has made no other calls on ARWR in the last 4 months.



There are 6 other peers that have a rating on ARWR. Out of the 6 peers that are also analyzing ARWR, 1 agrees with Luca's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $31 on, Wednesday, June 5th, 2024


These are the ratings of the 5 analyists that currently disagree with Luca


  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy on, Monday, September 9th, 2024
  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $60 on, Thursday, September 5th, 2024
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Monday, August 12th, 2024
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $60 on, Wednesday, July 17th, 2024
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy on, Thursday, June 20th, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com